Efficacy Of N-Acetyl-Cysteine as Adjuvant Therapy for Diabetic Foot Osteomyelitis: An Open-Label Randomized Controlled Trial

Laya Hooshmand Gharabagh ¹ , Mehdi Heydaroghli ² , Ayda Esmaeili ^3,4 *

Cited by CrossRef:

1- Golub A, Mikhailova N, Pomytkina M, Eremeeva K, Shevchik E, Nikiforova G, Svistushkin V, Korennaya V, Vasil’ev Y, Bakhrushina E. N-Acetylcysteine as a Bacterial Antibiofilm Adjuvant: Mechanisms, Synergistic Combinations and Clinical Translation. Life. 2026;16(9):1414 [Crossref]

2- Zhang H, Fu Z, Zhou Y, Wang S, Ye S, Wang A, Liu J. Immunometabolic reprogramming in diabetic osteomyelitis: from mechanisms to therapeutics. Front Cell Infect Microbiol. 2025;15 [Crossref]

3- Garehbagh L. Ethnobotanical Review of Medicinal Plants Used for the Treatment of Hypertension in the Southern Provinces of Iran. J Biochem Phytomed. 2025;4(1):40 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.